| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Mario M Rosati last filed a Form 4 in February 2025, as Director at SANM. The filings on record cover 2 companies. Mario M Rosati's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Mario M Rosati a middling insider score of 68/100, based on 15 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +8.1%.
At the last filing, the largest reported position was 80,295 shares of SANM. The SANM filings lean toward selling, a net 33,657 shares.
Mario M Rosati has 51 Form 4 filings on record from March 2015 to February 2025, across 2 companies: Director at Sanmina (SANM), 2015–2025; Director at Aehr Test Systems (AEHR), 2016–2023.
The 78 reported transactions were 25 option exercises, 22 open-market sales, 20 stock awards and 7 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 18 sales worth about $14.7M.
The largest open-market sale was 98,083 shares of AEHR at an average $36.42 on February 7, 2023, about $3.6M. Twelve months later AEHR was down 58%.
None of the 4 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from February 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | SANM Sanmina Corp | Director | Sell | 11,391 | $86.02 | $979,831.04 | -12.4% | -1.5% | +74.2% | |
| Aug 14, 2024 | SANM Sanmina Corp | Director | Sale+OE | 7,181 | $68.68 | $493,205.44 | -7.3% | +18.1% | +70.8% | |
| Feb 23, 2024 | SANM Sanmina Corp | Director | Sale+OE | 8,598 | $60.76 | $522,380.09 | -8.8% | +9.1% | +40.0% | |
| Jun 8, 2023 | AEHR Aehr Test Systems | Director | Sell | 1,742 | $40.95 | $71,335.87 | -100% | +28.4% | -68.3% | |
| Feb 7, 2023 | AEHR Aehr Test Systems | Director | Sell | 98,083 | $36.42 | $3,572,379.03 | -100% | -26.9% | -57.9% | |
| Feb 6, 2023 | AEHR Aehr Test Systems | Director | Sell | 52,933 | $36.19 | $1,915,842.19 | -35.1% | -25.6% | -58.0% | |
| Feb 2, 2023 | AEHR Aehr Test Systems | Director | Sell | 50,405 | $36.25 | $1,827,115.57 | -98.9% | -28.4% | -58.9% | |
| Jan 31, 2023 | AEHR Aehr Test Systems | Director | Sale+OE | 91,108 | $34.37 | $3,131,728.61 | - | -25.8% | -57.5% | |
| Jan 13, 2023 | AEHR Aehr Test Systems | Director | Sell | 17,291 | $28.64 | $495,153.72 | -25.7% | +1.9% | -40.3% | |
| Jan 11, 2023 | AEHR Aehr Test Systems | Director | Sell | 41,797 | $28.72 | $1,200,409.84 | -91.9% | +4.8% | -35.5% |